Preliminary Program

Perspectives in Congenital Heart Disease 2025: Heart Failure

Day 1

9.00 – 9.10 Opening - Thomas Krasemann (Rotterdam, NL) and Arie van Dijk (Nijmegen, NL)

Concepts:

9.10 - 9.25 Heart failure in crocodiles - Bjarke Jenssen (Amsterdam, NL)

9.25 -9.40 Left ventricular failure - Henk Schipper (Rotterdam, NL)

9.40 -9.55 Right ventricular failure - Beatrijs Bartelds (Rotterdam, NL)

9.55 - 10.10 Single ventricle failure - Wim Helbing (Rotterdam, NL)

10.10 - 10.40 Does age matter?

Pediatric perspective - Matthew Fenton (London, UK)
Adult perspective - Michelle Michels (Rotterdam, NL)

10.40 - 11.15: Coffee and refreshments

Diagnostics Imaging

11.15 - 11.30 Imaging Fontan failure with MRI- Emanuela Valsangiacomo (Zurich, CH)

11.30 - 11.45 Imaging cardiomyopathies with MRI - age dependent? - Lars Grosse-Wortmann (Portland, Or, USA)

11.45 - 12.00 Imaging and artificial intelligence: Vivek Muthurangu (London, UK)

12.00 - 12.15 Combining image modalities for treatment - Stanimir Georgiev (Munich, DE)

12.15 - 12.45 Which echo parameters predict heart failure?

Pediatric perspective - Hannah Bellsham-Revell (London, UK)
Adult perspective: - Annemien van den Bosch (Rotterdam, NL)

12.45 - 13.30 Lunch

Rhythm changes… everything?

13.30 - 13.45 Electrical principles of heart failure - Janneke Kammeraad (Rotterdam, NL)

13.45 - 14.00 How to avoid pacing induced heart failure - Nico Blom (Leiden, NL)

14.00 - 14.15 Interventional therapy of arrhythmic heart failure -  Sing Yap (Rotterdam, NL)

14.15 - 14.45 Heart block and heart failure: To pace or not to pace? - Petra Loureiro (Lisbon, P)

& Gert van den Berg (Rotterdam, NL)

14.45 - 15.10 Tea and refreshments

What else can we measure?

15.10 -15.25 Biomarkers in congenital heart disease - Petru Liuba (Lund, S)

15.25 - 15.40 Do exercise data help? – Wim Helbing (Rotterdam, NL)

15.40 - 15.55 Monitoring at home: Invasive versus non-invasive - Arend van Deutekom (Rotterdam, NL), E. Piccinelli (Rome, IT)

15.55 - 16.30 Pressure-volume loops: Do size and type of ventricle matter?

Pediatric perspective - Anselm Uebing (RV) (Kiel, DE),
Adult perspective - Nicolas Van Mieghem (LV) (Rotterdam, NL)

Day 2:

8.50-9.00 Welcome - Annemien van den Bosch (Rotterdam, NL) and Ewout Boesaard (Nijmegen, NL)

Treatment

9.00 - 9.15 Treatment targets –Matthew Fenton (London, UK)

9.15 - 9.30 Drugs for heart failure in congenital heart disease – any specifics? - Henk Schipper (Rotterdam, NL)

9.30 - 9.45 Catheter treatment of heart failure beyond valves - Gianfranco Butera (Rome, IT)

9.45 - 10.00 Future of assist devices - Jolanda Kluin (Rotterdam, NL)

10.00 - 10.30 Ultima ratio transplantation

Pediatric perspective - Matthew Fenton (London, UK),
Adult perspective - Martijn Kauling (Rotterdam, NL)

10.30 - 11.00: Coffee and refreshments

Prognosis

11.00 - 11.15 Of right ventricular failure in biventricular circulation – Alexander van de Bruaene (Leuven, BE)

11.15 - 11.30 Of right ventricle in single ventricular circulation - Hannah Bellsham-Revell (London, UK)

11.30 - 11.45 Of left ventricular cardiomyopathy - Sabine Klaassen (Berlin, DE)

11.45 – 12.00 Role of interaction between right and left ventricle in congenital heart disease. - Seppie Panzer (Leuven, BE)

12.00 - 12.30 Future of cardiac regenerative therapy.

Pediatric perspective - Beatrijs Bartelds (Rotterdam, NL).
Adult perspective - Jeroen Bakkers.(Utrecht, NL)

12.30 - 13.30 Lunch

Quality of life

13.30 - 13.45 Patient perspective - Joost Riphagen (Rotterdam, NL)

13.45 - 14.00 In adults with congenital heart disease - Philip Moons (Leuven, BE)

14.00 - 14.15 Do we really improve quality of life by performing more and more complex congenital heart catheterization?

A doctor's perspective - Caroline Ovaert (Marseille, F)

14.15 - 14.30 Quality of life after ECMO: Does patient age matter? - Karolijn Dulfer (Rotterdam, NL)

14.30 - 14.45 End-of life discussions. - Jolien Roos

Adjourn

14.45 – 15.00 Closing remarks – Thomas. Krasemann (Rotterdam, NL)